Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors

被引：0
|
作者：
Justin C. Kao
Adipong Brickshawana
Teerin Liewluck
机构：
[1] Auckland City Hospital,Department of Neurology
[2] Montefiore Medical Center,Department of Medicine
[3] Albert Einstein College of Medicine,Department of Neurology
[4] Mayo Clinic,undefined
来源：
Current Neurology and Neuroscience Reports | 2018年 / 18卷
关键词：
Myasthenia gravis; Myositis; Neuropathy; Nivolumab; Pembrolizumab; Programmed cell death-1 (PD-1) inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Kao, Justin C.
    Brickshawana, Adipong
    Liewluck, Teerin
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)
  • [2] Programmed death-1 (PD-1) Expression in Sezary Syndrome
    Wehkamp, U.
    Oschlies, I
    Brasch, J.
    Klapper, W.
    Weichenthal, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 922 - 922
  • [3] The Role of Programmed Cell Death-1 (PD-1) and Its Ligands in Pediatric Cancer
    van Dam, Laura S.
    de Zwart, Verena M.
    Meyer-Wentrup, Friederike A. G.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 190 - 197
  • [4] Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics
    Cassol, Clarissa A.
    Owen, Dwight
    Kendra, Kari
    Braga, Juarez R.
    Frankel, Wendy L.
    Arnold, Christina A.
    [J]. HISTOPATHOLOGY, 2020, 77 (02) : 240 - 249
  • [5] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [6] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [7] Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
    Mallett, Grace
    Laurence, Arian
    Amarnath, Shoba
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [8] Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable
    Prasad, Vinay
    Kaestner, Victoria
    [J]. SEMINARS IN ONCOLOGY, 2017, 44 (02) : 132 - 135
  • [9] Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
    Wang, Yu
    Huang, Kun
    Gao, Yali
    Yuan, Dandan
    Ling, Lin
    Liu, Jieqing
    Wu, Sihai
    Chen, Roufen
    Li, He
    Xiong, Yizu
    Liu, Han
    Ma, Junjie
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
  • [10] Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma
    Tang, Weifeng
    Chen, Yu
    Chen, Shuchen
    Sun, Bin
    Gu, Haiyong
    Kang, Mingqiang
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8086 - 8093
12345